Outsourcing global clinical

& medical engagement for accelerated drug approval

& acceptance

Flexible, scalable sales teams for rapid product launch

& lifecycle management

AnswerY™, an AI-driven, HIPAA-compliant platform of prescriber-patient conversations that drives next-best actions

Premium content & audience access to critical oncology care networks

Continuous growth for teams and individuals led by pharma industry experts

Pioneering Innovation

Our News

Dravet syndrome (DS) and Lennox-Gastaut syndrome (LGS) are rare, childhood-onset, developmental epileptic encephalopathies.
Explore Research arrow
May 30, 2025
There is a growing push to leverage diverse data sources to enrich RWD insights. 
Read Article arrow
May 29, 2025
Meet Ava, Amplity’s new AI-powered chatbot designed to deliver faster, more personalized digital experiences on .
Read Article arrow
May 28, 2025
Read Article arrow
May 22, 2025
Lung cancer is a common and deadly cancer in the United States.
Explore Research arrow
May 21, 2025
Early TKI Disruptions In ROS1+ NSCLC Reveal Treatment Gaps
Explore Research arrow
May 21, 2025
Myasthenia gravis (MG) is a rare, chronic, autoantibody-mediated neuromuscular disorder.
Explore Research arrow
May 21, 2025
NLP Unlocks Patterns In Myasthenia Gravis Progression
Explore Research arrow
May 21, 2025
Find out how Amplity used its AI-powered platform to highlight key trends on GLP-1 RAs and biologics at ISPOR 25.
Read Now arrow
May 15, 2025

Events and Webinars

No events to see right now — but exciting things are on the way! Check back soon.
Powerful Partnerships Start Here